This article writes of a new medication said to aid children with achondroplasia, which is a rare bone disorder that results in disproportionate trunk and limb size. Their maximum height is on average 4' 6. There were 120 children who were administered this new drug, vosoritide. The hope was that it will give the possibility of greater height and improved proportions. They were administered this drug for two years with excellent results. The patients ranged from ages 5 to 18. Before this study, these children averaged 1.67 inches in height within a year. Then with one year into the trial, the children had gained an average height of 2.23 inches. The next year added an extra 2.19 inches of height, on average. The drug also aided in improving body proportions and did not disappear over time.
I chose this article because of its positivity. I was happy to hear that this study was in fact a success and nothing waned over time. I am sure people with achondroplasia become sad at times, and having the possibility of this new drug as treatment is amazing!
I have seen some similar research which outlines the potential effectiveness of the HGH secretagogue and ghrelin agonist known as MK-677 (Ibutamoren) in similar treatments of stunted growth and growth hormone deficiency. Very interesting stuff.ReplyDelete
The team was organized and extremely skilled, providing a clear project outline and schedule. Opiate DetoxReplyDelete